Answers are grounded in this paper and cite their sources.
Antibodies against phosphorylcholine (anti-PC) have been reported as associated with protection against atherosclerosis, cardiovascular disease (CVD), and other chronic inflammatory diseases. Underlying potential mechanisms have been demonstrated and include anti-inflammatory, clearance of dead cells, and inhibition of oxidized low-density lipoprotein effects.
No takes yet. Share an insight, caveat, or question.
Frostegård et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: